Evidence mapPaperPMID 39393515Full record

ArticleMetabolism: clinical and experimental2025

A partial loss-of-function variant (Ile191Val) of the TAS1R2 glucose receptor is associated with enhanced responses to exercise training in older adults with obesity: A translational study.

Joan Serrano, Saki Kondo, Grace M Link, Ian S Brown, Richard E Pratley, Kedryn K Baskin, Bret H Goodpaster, Paul M Coen, George A Kyriazis

Abstract read
In one paragraph

Article in Metabolism: clinical and experimental, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Joan SerranoBiological Chemistry & Pharmacology, College of Medicine, The Ohio State University, Columbus, OH, USA.
Saki KondoBiological Chemistry & Pharmacology, College of Medicine, The Ohio State University, Columbus, OH, USA.
Grace M LinkBiological Chemistry & Pharmacology, College of Medicine, The Ohio State University, Columbus, OH, USA.
Ian S BrownBiological Chemistry & Pharmacology, College of Medicine, The Ohio State University, Columbus, OH, USA.
Richard E PratleyTranslational Research Institute, Advent Health, Orlando, FL, USA.
Kedryn K BaskinPhysiology & Cell Biology College of Medicine, The Ohio State University, Columbus, OH, USA.
Bret H GoodpasterTranslational Research Institute, Advent Health, Orlando, FL, USA.
Paul M CoenTranslational Research Institute, Advent Health, Orlando, FL, USA. Electronic address: Paul.Coen@AdventHealth.com.
George A KyriazisBiological Chemistry & Pharmacology, College of Medicine, The Ohio State University, Columbus, OH, USA. Electronic address: Georgios.Kyriazis@osumc.edu.

Funding

Pilot and Feasibility ProgramP30DK020572 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · 2022 to 2025
$4.9M
Receptor-mediated glucose sensing and skeletal muscle functionR01DK127444 · NIDDK · OHIO STATE UNIVERSITY · 2022 to 2025
$1.5M
Skeletal Muscle Lipid and Insulin Resistance in AgingR01AG021961 · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · 2004 to 2005
$646k
NIA NIH HHS R01 AG021961NIDDK NIH HHS P30 DK020572NIDDK NIH HHS R01 DK127444
6 · The paper itself

Abstract

backgroundThe TAS1R2 receptor, known for its role in taste perception, has also emerged as a key regulator of muscle physiology. Previous studies have shown that genetic ablation of TAS1R2 in mice enhances muscle fitness mimicking responses to endurance exercise training. However, the translational relevance of these findings to humans remains uncertain.

methodsWe explored responses to endurance exercise training in mice and humans with genetic deficiency of TAS1R2. First, we assessed the effects of muscle-specific deletion of TAS1R2 in mice (mKO) or wild type controls (mWT) following 4 weeks of voluntary wheel running (VWR). Next, we investigated the effects of the TAS1R2

resultsIn response to VWR, mKO mice demonstrated enhanced running endurance and mitochondrial protein content. Similarly, TAS1R2 Val carriers exhibited distinctive improvements in body composition, including increased muscle mass, along with enhanced cardiorespiratory fitness and mitochondrial function in skeletal muscle following the WLEX intervention compared to Ile/Ile counterparts. Notably, every Val carrier demonstrated substantial responses to exercise training and weight loss, surpassing all Ile/Ile participants in overall performance metrics.

conclusionsOur findings suggest that TAS1R2 partial loss-of-function confers beneficial effects on muscle function and metabolism in humans in response to exercise training, akin to observations in TAS1R2 muscle-deficient mice. Targeting TAS1R2 may help enhancing exercise training adaptations in individuals with compromised exercise tolerance or metabolic disorders, presenting a potential avenue for personalized exercise interventions.

Indexed as

ObesityReceptors, G-Protein-CoupledAgedAnimalsExerciseFemaleHumansLoss of Function MutationMaleMiceMice, Inbred C57BLMice, KnockoutMiddle AgedMuscle, SkeletalPhysical Conditioning, AnimalRetrospective StudiesReceptors, G-Protein-Coupledtaste receptors, type 1AgingExerciseGeneticsHbA1cMitochondriaMuscle massMuscle metabolismNADObesityPDEPolymorphismrs35874116RunningSweet taste receptorTAS1R2Weight loss

Identifiers

PMID39393515
PMCPMC11637915

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.